Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain B, pheromone binding protein | 0 | 0 | 1 | 1 |
Chain A, pheromone binding protein | 0 | 0 | 1 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 4 | 0 | 0 | 4 |
Chain A, RNA-directed RNA polymerase NS5 | 0 | 1 | 0 | 1 |
acid sphingomyelinase | 2 | 0 | 0 | 2 |
thioredoxin reductase | 5 | 0 | 0 | 5 |
USP1 protein, partial | 7 | 0 | 0 | 7 |
TDP1 protein | 8 | 0 | 0 | 8 |
vitamin D3 receptor isoform VDRA | 3 | 0 | 0 | 3 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
flap endonuclease 1 | 4 | 0 | 0 | 4 |
serine/threonine-protein kinase PLK1 | 2 | 0 | 0 | 2 |
snurportin-1 | 1 | 0 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 2 | 0 | 0 | 2 |
urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
plasminogen precursor | 2 | 0 | 0 | 2 |
urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
geminin | 8 | 0 | 0 | 8 |
DNA polymerase kappa isoform 1 | 3 | 0 | 0 | 3 |
fibroblast growth factor 22 isoform 1 precursor | 0 | 0 | 0 | 1 |
Mitogen-activated protein kinase 13 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Transthyretin | 0 | 1 | 1 | 2 |
Fatty acid-binding protein, intestinal | 0 | 4 | 2 | 6 |
Fatty acid-binding protein, adipocyte | 0 | 5 | 2 | 7 |
Cyclin-A2 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 0 | 1 | 1 |
Cyclin-dependent kinase 2 | 0 | 1 | 1 | 2 |
Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 12 | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
Fatty acid-binding protein 5 | 0 | 3 | 2 | 5 |
Fatty acid-binding protein 5 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase 11 | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 14 | 0 | 2 | 0 | 2 |
Chain A, High-affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Chain A, Phosphodiesterase 9A | 0 | 1 | 0 | 1 |
Chain A, Class I phosphodiesterase PDEB1 | 0 | 1 | 0 | 1 |
Chain A, High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 1 | 0 | 1 |
Chain A, cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase catalytic domain, Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha chimera | 0 | 1 | 0 | 1 |
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase catalytic domain, Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha chimera | 0 | 1 | 0 | 1 |
Chain A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | 0 | 1 | 0 | 1 |
Chain A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | 0 | 1 | 0 | 1 |
glp-1 receptor, partial | 2 | 0 | 0 | 2 |
thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
estrogen-related nuclear receptor alpha | 7 | 0 | 0 | 7 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
mitogen-activated protein kinase 1 | 3 | 0 | 0 | 3 |
cytochrome P450 3A4 isoform 1 | 5 | 0 | 0 | 5 |
histone acetyltransferase KAT2A isoform 1 | 4 | 0 | 0 | 4 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 5 | 1 | 1 | 7 |
Monocarboxylate transporter 4 | 0 | 1 | 0 | 1 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 1 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 2 | 0 | 2 |
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | 0 | 1 | 0 | 1 |
Renin | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 5 | 1 | 1 | 7 |
Gamma-aminobutyric acid receptor subunit delta | 5 | 1 | 1 | 7 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 5 | 1 | 1 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 5 | 1 | 1 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 5 | 1 | 1 | 7 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 5 | 2 | 1 | 8 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 5 | 1 | 1 | 7 |
Adenosine receptor A1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 5 | 1 | 1 | 7 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 5 | 1 | 1 | 7 |
Adenosine receptor A3 | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 3 | 1 | 5 |
Adenosine receptor A2b | 0 | 0 | 0 | 1 |
Adenosine receptor A2b | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 5 | 1 | 1 | 7 |
Adenosine receptor A1 | 0 | 2 | 1 | 5 |
Adenosine receptor A2a | 0 | 3 | 0 | 3 |
Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 5 | 1 | 1 | 7 |
Gamma-aminobutyric acid receptor subunit beta-3 | 5 | 1 | 1 | 7 |
Gamma-aminobutyric acid receptor subunit beta-2 | 5 | 1 | 1 | 7 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 2 | 0 | 2 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
GABA theta subunit | 5 | 1 | 1 | 7 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 5 | 1 | 1 | 7 |
cAMP-specific 3',5'-cyclic phosphodiesterase 7B | 0 | 1 | 0 | 1 |
15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
Microtubule-associated protein tau | 4 | 0 | 0 | 4 |
glucocerebrosidase | 2 | 0 | 0 | 2 |
lethal factor (plasmid) | 2 | 0 | 0 | 2 |
Glutamate receptor 1 | 0 | 3 | 1 | 4 |
Glutamate receptor 2 | 0 | 3 | 1 | 4 |
Glutamate receptor 3 | 0 | 3 | 0 | 3 |
Glutamate receptor 4 | 0 | 3 | 0 | 3 |
Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
arylsulfatase A | 3 | 0 | 0 | 3 |
euchromatic histone-lysine N-methyltransferase 2 | 6 | 0 | 0 | 6 |
chromobox protein homolog 1 | 4 | 0 | 0 | 4 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 2 | 3 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 2 | 3 |
Integrin beta-3 | 1 | 1 | 0 | 2 |
Integrin alpha-IIb | 1 | 1 | 0 | 2 |
Glutamate receptor 1 | 0 | 2 | 1 | 3 |
Glutamate receptor 2 | 4 | 2 | 1 | 7 |
Glutamate receptor 3 | 0 | 2 | 1 | 3 |
Glutamate receptor 4 | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, kainate 1 | 0 | 2 | 0 | 2 |
Glutamate receptor 1 | 0 | 1 | 1 | 2 |
Glutamate receptor 2 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, kainate 1 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, kainate 2 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, kainate 3 | 0 | 1 | 0 | 1 |
Excitatory amino acid transporter 1 | 0 | 1 | 0 | 1 |
Excitatory amino acid transporter 2 | 0 | 1 | 0 | 1 |
Excitatory amino acid transporter 3 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, kainate 4 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 2 | 3 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 2 | 3 |
Glutamate receptor ionotropic, kainate 2 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, kainate 3 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 2 | 3 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 2 | 3 |
Glutamate receptor ionotropic, kainate 4 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, kainate 5 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, kainate 5 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 2 | 3 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 0 | 2 |
Glutamate receptor 4 | 0 | 1 | 0 | 1 |
Glutamate receptor 3 | 0 | 1 | 0 | 1 |
Chain A, Cruzipain | 2 | 0 | 0 | 2 |
RAR-related orphan receptor gamma | 7 | 0 | 0 | 7 |
SMAD family member 2 | 3 | 0 | 0 | 3 |
SMAD family member 3 | 3 | 0 | 0 | 3 |
GLI family zinc finger 3 | 5 | 0 | 0 | 5 |
AR protein | 7 | 0 | 0 | 7 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
estrogen receptor 2 (ER beta) | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 3 | 6 | 0 | 0 | 6 |
glucocorticoid receptor [Homo sapiens] | 6 | 0 | 0 | 6 |
retinoic acid nuclear receptor alpha variant 1 | 7 | 0 | 0 | 7 |
retinoid X nuclear receptor alpha | 4 | 0 | 0 | 4 |
pregnane X nuclear receptor | 5 | 0 | 0 | 5 |
estrogen nuclear receptor alpha | 10 | 0 | 0 | 10 |
peroxisome proliferator-activated receptor delta | 6 | 0 | 0 | 6 |
peroxisome proliferator activated receptor gamma | 8 | 0 | 0 | 8 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 5 | 0 | 0 | 5 |
caspase-3 | 1 | 0 | 0 | 1 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 6 | 0 | 0 | 6 |
Caspase-7 | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform a | 3 | 0 | 0 | 3 |
caspase-3 | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform 2 | 7 | 0 | 0 | 7 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 6 | 0 | 0 | 6 |
Voltage-dependent calcium channel gamma-2 subunit | 4 | 0 | 0 | 4 |
Solute carrier organic anion transporter family member 2B1 | 0 | 0 | 0 | 1 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 2 | 0 | 2 |
Cellular tumor antigen p53 | 7 | 0 | 0 | 7 |
ATP-dependent translocase ABCB1 | 0 | 3 | 1 | 4 |
Insulin receptor | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
Histone deacetylase 1 | 0 | 3 | 0 | 3 |
Histone deacetylase 2 | 0 | 3 | 0 | 3 |
Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 3 |
Histone deacetylase 6 | 0 | 3 | 0 | 3 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 3 | 0 | 3 |
Solute carrier organic anion transporter family member 1B1 | 0 | 3 | 0 | 4 |
Luciferase | 6 | 0 | 0 | 6 |
phosphopantetheinyl transferase | 3 | 0 | 0 | 3 |
aldehyde dehydrogenase 1 family, member A1 | 5 | 0 | 0 | 5 |
farnesoid X nuclear receptor | 7 | 0 | 0 | 7 |
G | 4 | 0 | 0 | 4 |
D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
survival motor neuron protein isoform d | 3 | 0 | 0 | 3 |
Bile salt export pump | 0 | 5 | 0 | 5 |
5-hydroxytryptamine receptor 4 | 0 | 6 | 2 | 8 |
Bile salt export pump | 0 | 8 | 0 | 8 |
Interferon beta | 4 | 0 | 0 | 4 |
HLA class I histocompatibility antigen, B alpha chain | 4 | 0 | 0 | 4 |
Fatty acid-binding protein, liver | 0 | 3 | 1 | 4 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 4 | 4 |
Muscarinic acetylcholine receptor M3 | 0 | 0 | 4 | 4 |
Muscarinic acetylcholine receptor M4 | 0 | 0 | 4 | 4 |
Muscarinic acetylcholine receptor M5 | 0 | 0 | 4 | 4 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 4 | 4 |
Peroxisome proliferator-activated receptor alpha | 0 | 2 | 3 | 5 |
Peroxisome proliferator-activated receptor delta | 0 | 0 | 1 | 1 |
Peroxisome proliferator-activated receptor gamma | 0 | 5 | 7 | 14 |
Peroxisome proliferator-activated receptor gamma | 0 | 1 | 4 | 5 |
Peroxisome proliferator-activated receptor delta | 0 | 2 | 2 | 5 |
Peroxisome proliferator-activated receptor alpha | 2 | 4 | 6 | 12 |
Inositol hexakisphosphate kinase 1 | 4 | 0 | 0 | 4 |
cytochrome P450 2C9, partial | 4 | 0 | 0 | 4 |
Chain A, Protein (peroxisome Proliferator Activated Receptor (ppar-delta)) | 0 | 1 | 0 | 1 |
GLS protein | 2 | 0 | 0 | 2 |
regulator of G-protein signaling 4 | 1 | 0 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 2 | 0 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
Trypsin | 0 | 2 | 0 | 2 |
Cytochrome P450 1A2 | 0 | 2 | 0 | 2 |
Coagulation factor VII | 0 | 2 | 0 | 2 |
Aromatase | 0 | 3 | 0 | 3 |
Tissue factor | 0 | 3 | 0 | 3 |
Retinoic acid receptor RXR-alpha | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
Oxoeicosanoid receptor 1 | 0 | 1 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 3 | 0 | 0 | 3 |
Chain A, Ferritin light chain | 3 | 0 | 0 | 3 |
endonuclease IV | 1 | 0 | 0 | 1 |
ATAD5 protein, partial | 4 | 0 | 0 | 4 |
progesterone receptor | 3 | 0 | 0 | 3 |
EWS/FLI fusion protein | 5 | 0 | 0 | 5 |
nonstructural protein 1 | 2 | 0 | 0 | 2 |
bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 3 | 0 | 0 | 3 |
serine-protein kinase ATM isoform a | 2 | 0 | 0 | 2 |
Bloom syndrome protein isoform 1 | 3 | 0 | 0 | 3 |
peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
cytochrome P450 2C19 precursor | 2 | 0 | 0 | 2 |
cytochrome P450 2C9 precursor | 2 | 0 | 0 | 2 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 3 | 0 | 0 | 3 |
potassium voltage-gated channel subfamily H member 2 isoform d | 2 | 0 | 0 | 2 |
heat shock protein beta-1 | 2 | 0 | 0 | 2 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
nuclear receptor ROR-gamma isoform 1 | 2 | 0 | 0 | 2 |
M-phase phosphoprotein 8 | 2 | 0 | 0 | 2 |
muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 5 | 0 | 0 | 5 |
neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
ATP-binding cassette sub-family C member 3 | 0 | 6 | 0 | 6 |
Multidrug resistance-associated protein 4 | 0 | 6 | 0 | 6 |
Fatty acid-binding protein, liver | 0 | 1 | 1 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 3 | 0 | 3 |
Adenosine receptor A3 | 0 | 3 | 1 | 4 |
Beta-3 adrenergic receptor | 0 | 4 | 1 | 5 |
Alpha-1B adrenergic receptor | 0 | 3 | 1 | 4 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
Cruzipain | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 6 | 1 | 7 |
5-hydroxytryptamine receptor 2C | 0 | 6 | 1 | 7 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
Peroxisome proliferator-activated receptor alpha | 0 | 0 | 1 | 1 |
Alpha-1A adrenergic receptor | 0 | 3 | 1 | 4 |
Histamine H2 receptor | 2 | 0 | 0 | 2 |
Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
Canalicular multispecific organic anion transporter 1 | 0 | 4 | 0 | 4 |
Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
ATP-dependent phosphofructokinase | 1 | 0 | 0 | 1 |
Chain A, Estrogen receptor 1 (alpha) | 0 | 1 | 0 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
BRCA1 | 1 | 0 | 0 | 1 |
PPM1D protein | 1 | 0 | 0 | 1 |
Thrombopoietin | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 4 | 0 | 0 | 4 |
cytochrome P450 2D6 | 1 | 0 | 0 | 1 |
Neuraminidase | 0 | 1 | 0 | 1 |
67.9K protein | 1 | 0 | 0 | 1 |
Parkin | 2 | 0 | 0 | 2 |
P53 | 1 | 0 | 0 | 1 |
Alpha-mannosidase | 0 | 1 | 0 | 1 |
pyruvate kinase | 1 | 0 | 0 | 1 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
activating transcription factor 6 | 1 | 0 | 0 | 1 |
Histone H2A.x | 1 | 0 | 0 | 1 |
hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 2 | 0 | 0 | 2 |
histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
glucokinase regulatory protein | 1 | 0 | 0 | 1 |
glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
DNA polymerase beta | 1 | 0 | 0 | 1 |
ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
tyrosine-protein kinase Yes | 2 | 0 | 0 | 2 |
peripheral myelin protein 22 | 3 | 0 | 0 | 3 |
pyruvate kinase PKM isoform b | 1 | 0 | 0 | 1 |
Maltase-glucoamylase, intestinal | 0 | 2 | 0 | 2 |
Steroid hormone receptor ERR2 | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase ABL1 | 0 | 1 | 0 | 1 |
Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
Pancreatic triacylglycerol lipase | 0 | 1 | 0 | 1 |
Triosephosphate isomerase | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 3 | 2 | 5 |
Glucocorticoid receptor | 0 | 2 | 1 | 4 |
Sex hormone-binding globulin | 0 | 0 | 2 | 2 |
Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
Ornithine decarboxylase | 1 | 0 | 0 | 1 |
Androgen receptor | 0 | 3 | 2 | 6 |
Sialidase | 0 | 1 | 0 | 1 |
Solute carrier family 2, facilitated glucose transporter member 1 | 0 | 1 | 0 | 1 |
Tyrosinase | 0 | 1 | 0 | 1 |
Steroid hormone receptor ERR1 | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 4 | 0 | 1 | 0 | 1 |
Ornithine decarboxylase | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
Cystic fibrosis transmembrane conductance regulator | 0 | 0 | 1 | 1 |
17-beta-hydroxysteroid dehydrogenase type 1 | 0 | 1 | 0 | 1 |
Solute carrier family 2, facilitated glucose transporter member 4 | 0 | 1 | 0 | 1 |
G2/mitotic-specific cyclin-B1 | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Androgen receptor | 0 | 3 | 0 | 3 |
Protein kinase C alpha type | 0 | 1 | 0 | 2 |
cAMP-dependent protein kinase catalytic subunit alpha | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 3 | 0 | 3 |
Amine oxidase [flavin-containing] A | 0 | 3 | 0 | 3 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
G1/S-specific cyclin-D1 | 0 | 1 | 0 | 1 |
Thromboxane-A synthase | 0 | 2 | 0 | 2 |
DNA (cytosine-5)-methyltransferase 1 | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 5 | 0 | 5 |
Dipeptidyl peptidase 4 | 0 | 2 | 0 | 2 |
Proteasome subunit beta type-5 | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 1 | 0 | 1 |
RAC-alpha serine/threonine-protein kinase | 0 | 1 | 0 | 1 |
Cystic fibrosis transmembrane conductance regulator | 0 | 0 | 1 | 1 |
Testosterone 17-beta-dehydrogenase 3 | 0 | 1 | 0 | 1 |
17-beta-hydroxysteroid dehydrogenase type 2 | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Alpha-glucosidase MAL32 | 0 | 1 | 0 | 1 |
Signal transducer and activator of transcription 3 | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase CSK | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase ABL2 | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase SYK | 0 | 1 | 0 | 1 |
Dual specificity mitogen-activated protein kinase kinase 4 | 0 | 1 | 0 | 1 |
Quinone oxidoreductase | 0 | 0 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
Cytoplasmic tyrosine-protein kinase BMX | 0 | 1 | 0 | 1 |
Death-associated protein kinase 1 | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 10 | 0 | 1 | 0 | 1 |
Oxysterols receptor LXR-beta | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Spike glycoprotein | 3 | 0 | 0 | 3 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
MO15-related protein kinase Pfmrk | 0 | 1 | 0 | 1 |
Aldehyde oxidase | 0 | 1 | 0 | 1 |
Oxysterols receptor LXR-alpha | 0 | 1 | 0 | 1 |
Tissue alpha-L-fucosidase | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Integrase | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 3 | 2 | 5 |
Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein) | 0 | 1 | 0 | 1 |
ATPase family AAA domain-containing protein 5 | 2 | 0 | 0 | 2 |
Ataxin-2 | 3 | 0 | 0 | 3 |
Prenyltransferase homolog | 0 | 0 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 3 | 0 | 1 | 0 | 1 |
DNA (cytosine-5)-methyltransferase 3-like | 0 | 1 | 0 | 1 |
Sialidase-2 | 0 | 1 | 0 | 1 |
DNA (cytosine-5)-methyltransferase 3A | 0 | 1 | 0 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 3 | 0 | 0 | 3 |
Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
interleukin 8 | 1 | 0 | 0 | 1 |
pregnane X receptor | 2 | 0 | 0 | 2 |
PINK1 | 1 | 0 | 0 | 1 |
IDH1 | 1 | 0 | 0 | 1 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 2 | 0 | 0 | 2 |
nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 1 | 0 | 0 | 1 |
transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
Progesterone receptor | 0 | 2 | 1 | 3 |
Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Androgen receptor | 0 | 0 | 1 | 1 |
Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Histamine H2 receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 3 | 0 | 3 |
Alpha-synuclein | 1 | 0 | 0 | 1 |
Aldo-keto reductase family 1 member C3 | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 3 | 0 | 0 | 3 |
Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 0 | 0 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
Chain A, Adipocyte Lipid-binding Protein | 0 | 0 | 1 | 1 |
Chain A, SERUM ALBUMIN | 0 | 0 | 1 | 1 |
Chain A, SERUM ALBUMIN | 0 | 0 | 1 | 1 |
Chain A, MUSCLE FATTY ACID BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain A, MUSCLE FATTY ACID BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain A, MUSCLE FATTY ACID BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
putative potassium channel subunit | 0 | 0 | 1 | 1 |
hypoxia-inducible factor 1 alpha subunit | 1 | 0 | 0 | 1 |
bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
DNA topoisomerase 1 | 0 | 1 | 0 | 1 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 4 | 0 | 4 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 2 | 0 | 2 | 0 | 2 |
Chain A, Fatty acid-binding protein, adipocyte | 0 | 1 | 0 | 1 |
acetylcholinesterase | 1 | 0 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Toll-like receptor 2 | 0 | 1 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
Free fatty acid receptor 1 | 0 | 0 | 2 | 2 |
Peroxisome proliferator-activated receptor gamma | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
Steryl-sulfatase | 0 | 1 | 0 | 1 |
Carnitine O-palmitoyltransferase 2, mitochondrial | 0 | 2 | 0 | 2 |
Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
Carnitine O-palmitoyltransferase 2, mitochondrial | 0 | 2 | 0 | 2 |
Carnitine O-palmitoyltransferase 1, liver isoform | 0 | 2 | 0 | 2 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
CDGSH iron-sulfur domain-containing protein 2 | 0 | 2 | 0 | 2 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 4 | 0 | 4 |
Beta-1 adrenergic receptor | 0 | 1 | 1 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Albumin | 0 | 0 | 1 | 1 |
Beta-2 adrenergic receptor | 0 | 2 | 1 | 3 |
Muscarinic acetylcholine receptor M2 | 0 | 1 | 1 | 2 |
Beta-1 adrenergic receptor | 0 | 2 | 1 | 3 |
Cytochrome P450 3A4 | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 2 | 4 |
Beta-2 adrenergic receptor | 0 | 2 | 0 | 3 |
Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 1 | 1 | 2 |
Cytochrome P450 2C9 | 0 | 1 | 1 | 2 |
D(2) dopamine receptor | 0 | 1 | 1 | 2 |
Alpha-2B adrenergic receptor | 0 | 0 | 1 | 2 |
Beta-1 adrenergic receptor | 0 | 2 | 1 | 4 |
Alpha-2C adrenergic receptor | 0 | 1 | 2 | 4 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 2 | 1 | 4 |
Alpha-2B adrenergic receptor | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 1 | 1 | 2 |
D(1A) dopamine receptor | 0 | 1 | 1 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 0 | 1 | 1 |
Alpha-2A adrenergic receptor | 0 | 0 | 1 | 1 |
Alpha-1D adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-1D adrenergic receptor | 0 | 0 | 1 | 2 |
Endothelin-1 receptor | 0 | 1 | 1 | 2 |
Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 2 | 1 | 3 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 1 | 2 |
Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 2 | 4 |
Alpha-1B adrenergic receptor | 0 | 0 | 1 | 2 |
Mu-type opioid receptor | 0 | 1 | 1 | 2 |
Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
Delta-type opioid receptor | 0 | 1 | 1 | 2 |
Kappa-type opioid receptor | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 6 | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 2 | 0 | 2 |
Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
Sodium/bile acid cotransporter | 0 | 2 | 0 | 2 |
Beta-2 adrenergic receptor | 0 | 1 | 1 | 3 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
Cytochrome P450 3A5 | 0 | 0 | 1 | 1 |
Catechol O-methyltransferase | 0 | 0 | 1 | 1 |
C-C chemokine receptor type 2 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 2 | 0 | 0 | 1 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 8 | 0 | 1 | 0 | 1 |
ATP-sensitive inward rectifier potassium channel 11 | 0 | 1 | 0 | 1 |
Thrombin | 0 | 0 | 1 | 1 |
Cocaine esterase | 0 | 1 | 0 | 1 |
Histone deacetylase 3 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
Cytochrome P450 2A6 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 1-6 | 0 | 0 | 0 | 1 |
Liver carboxylesterase 1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Histone deacetylase 4 | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B7 | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Histone deacetylase 7 | 0 | 2 | 0 | 2 |
Polyamine deacetylase HDAC10 | 0 | 2 | 0 | 2 |
Histone deacetylase 11 | 0 | 2 | 0 | 2 |
Histone deacetylase 8 | 0 | 2 | 0 | 2 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
Histone deacetylase 9 | 0 | 2 | 0 | 2 |
Histone deacetylase 5 | 0 | 2 | 0 | 2 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |